Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIVO
451
DELISTED
Tivo Inc
TIVO
| $19.7M | 0.05% |
+864,171
| New | +$20.3M |
|
452
Dick's Sporting Goods
DKS
$18.2B
| $19.7M | 0.05% |
+393,400
| New | +$19.7M |
|
453
Community Health Systems
CYH
$406M
| $19.6M | 0.05% |
+506,264
| New | +$19.1M |
|
|
DRC
454
DELISTED
DRESSER-RAND GROUP INC
DRC
| $19.6M | 0.05% |
+326,000
| New | +$19.3M |
|
455
Tenet Healthcare
THC
$21.3B
| $19.5M | 0.05% |
+422,575
| New | +$18.9M |
|
456
Rithm Capital
RITM
$5.71B
| $19.4M | 0.05% |
+1,441,904
| New | +$19.2M |
|
|
PPLI
457
People Inc
PPLI
$3.05B
| $19.4M | 0.05% |
+2,284,196
| New | +$19.5M |
|
458
Texas Roadhouse
TXRH
$14B
| $19.3M | 0.05% |
+771,272
| New | +$17.6M |
|
|
TCO
459
DELISTED
Taubman Centers Inc.
TCO
| $19.2M | 0.05% |
+256,100
| New | +$20.9M |
|
|
HERO
460
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $19.2M | 0.05% |
+2,732,703
| New | +$19.4M |
|
|
AZPN
461
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $19.2M | 0.05% |
+667,400
| New | +$19.2M |
|
462
Eastman Chemical
EMN
$8.35B
| $19.2M | 0.05% |
+274,340
| New | +$19.1M |
|
|
RTN
463
DELISTED
Raytheon Company
RTN
| $19.2M | 0.05% |
+290,400
| New | +$18.4M |
|
464
A.O. Smith
AOS
$8.5B
| $19.1M | 0.05% |
+1,055,600
| New | +$19.7M |
|
465
Tesla
TSLA
$1.29T
| $19.1M | 0.05% |
+2,667,000
| New | +$13.4M |
|
466
Boston Beer
SAM
$1.89B
| $19.1M | 0.05% |
+111,700
| New | +$17.7M |
|
467
SiriusXM
SIRI
$9.54B
| $18.9M | 0.05% |
+565,671
| New | +$18.6M |
|
468
Euronet Worldwide
EEFT
$2.61B
| $18.9M | 0.05% |
+593,445
| New | +$17.8M |
|
|
IPXL
469
DELISTED
Impax Laboratories, Inc.
IPXL
| $18.9M | 0.05% |
+946,300
| New | +$16.8M |
|
|
CAM
470
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $18.9M | 0.05% |
+308,291
| New | +$19.2M |
|
|
VOLC
471
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $18.8M | 0.05% |
+1,039,300
| New | +$19.9M |
|
|
ISBC
472
DELISTED
Investors Bancorp, Inc.
ISBC
| $18.8M | 0.05% |
+2,277,577
| New | +$17.6M |
|
|
WR
473
DELISTED
Westar Energy Inc
WR
| $18.8M | 0.05% |
+589,000
| New | +$19.3M |
|
474
Grupo Aeroportuario del Sureste
ASR
$8.19B
| $18.8M | 0.05% |
+169,100
| New | +$20.4M |
|
|
NRF
475
DELISTED
NorthStar Realty Finance Corp.
NRF
| $18.7M | 0.05% |
+1,048,588
| New | +$19.1M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.